Koninklijke Dsm Nv Stock Revenue
Koninklijke DSM NV fundamentals help investors to digest information that contributes to Koninklijke DSM's financial success or failures. It also enables traders to predict the movement of Koninklijke OTC Stock. The fundamental analysis module provides a way to measure Koninklijke DSM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Koninklijke DSM otc stock.
Koninklijke |
Koninklijke DSM NV OTC Stock Revenue Analysis
Koninklijke DSM's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Koninklijke DSM Revenue | 9.2 B |
Most of Koninklijke DSM's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke DSM NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Koninklijke DSM NV reported 9.2 B of revenue. This is 17.12% higher than that of the Basic Materials sector and 106.83% higher than that of the Specialty Chemicals industry. The revenue for all United States stocks is 2.45% higher than that of the company.
Koninklijke Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Koninklijke DSM's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Koninklijke DSM could also be used in its relative valuation, which is a method of valuing Koninklijke DSM by comparing valuation metrics of similar companies.Koninklijke DSM is currently under evaluation in revenue category among its peers.
Koninklijke Fundamentals
Return On Equity | 0.12 | |||
Return On Asset | 0.0402 | |||
Profit Margin | 0.11 % | |||
Operating Margin | 0.10 % | |||
Current Valuation | 24.43 B | |||
Shares Outstanding | 691.88 M | |||
Shares Owned By Institutions | 0.15 % | |||
Price To Earning | 38.86 X | |||
Price To Book | 2.36 X | |||
Price To Sales | 2.39 X | |||
Revenue | 9.2 B | |||
Gross Profit | 3.16 B | |||
EBITDA | 1.71 B | |||
Net Income | 1.68 B | |||
Cash And Equivalents | 1.63 B | |||
Cash Per Share | 2.36 X | |||
Total Debt | 2.84 B | |||
Debt To Equity | 0.31 % | |||
Current Ratio | 2.51 X | |||
Book Value Per Share | 14.09 X | |||
Cash Flow From Operations | 1.43 B | |||
Earnings Per Share | 1.59 X | |||
Price To Earnings To Growth | 2.81 X | |||
Target Price | 44.0 | |||
Number Of Employees | 21.76 K | |||
Beta | 0.79 | |||
Market Capitalization | 23.42 B | |||
Total Asset | 16.01 B | |||
Z Score | 4.2 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 1.95 % | |||
Net Asset | 16.01 B | |||
Last Dividend Paid | 2.63 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Koninklijke OTC Stock
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets |